Advertisements

Pharma cos leaning on $850,000 therapy to justify super-expensive drugs

Pharma cos leaning on $850,000 therapy to justify super-expensive drugs.....»»

Category: topSource: business-standardJan 12th, 2018

Gilead to buy Kite for promising cancer therapies in $12 bln deal

Gilead to buy Kite for promising cancer therapies in $12 bln deal.....»»

Category: global-financeSource: reutersAug 28th, 2017

Gilead to buy Kite for promising cancer therapies in $12 billion deal

Gilead to buy Kite for promising cancer therapies in $12 billion deal.....»»

Category: global-financeSource: reutersAug 28th, 2017

Over-the-counter route to accelerate sales growth for domestic pharma firms

Over-the-counter route to accelerate sales growth for domestic pharma firms.....»»

Category: featuresSource: business-standardJan 15th, 2018

Analysis: Drugmakers see a pricing blueprint in an $850,000 gene therapy

Analysis: Drugmakers see a pricing blueprint in an $850,000 gene therapy.....»»

Category: global-financeSource: reutersJan 13th, 2018

Pharma companies focus on limited competition drugs for the US market

Pharma companies focus on limited competition drugs for the US market.....»»

Category: featuresSource: business-standardJan 9th, 2018

DCGI bans import of drug ingredients from six Chinese firms

DCGI bans import of drug ingredients from six Chinese firms.....»»

Category: featuresSource: livemintJan 7th, 2018

Indian pharma should look beyond generics

Indian pharma should look beyond generics.....»»

Category: featuresSource: business-standardJan 3rd, 2018

Broker’s Call: Mangalam Drugs (Buy)

Broker’s Call: Mangalam Drugs (Buy).....»»

Category: marketsSource: thehindubusinesslineDec 26th, 2017

News in Numbers: NHAI plans to award road contracts for 10,000km in 2017-18

News in Numbers: NHAI plans to award road contracts for 10,000km in 2017-18.....»»

Category: economySource: livemintDec 20th, 2017

Roche touts Swiss-led R&D unit after years in Genentech"s shadow

Roche touts Swiss-led R&D unit after years in Genentech"s shadow.....»»

Category: global-financeSource: reutersDec 19th, 2017

Sun Pharma"s specialty drugs face competition in US

Sun Pharma"s specialty drugs face competition in US.....»»

Category: featuresSource: business-standardDec 12th, 2017

Dept of Pharma sets up committee to assist on pricing, new drug launches

Dept of Pharma sets up committee to assist on pricing, new drug launches.....»»

Category: topSource: moneycontrolDec 3rd, 2017

DoP sets up high level panel to assist on pricing, launch of new drugs

DoP sets up high level panel to assist on pricing, launch of new drugs.....»»

Category: featuresSource: livemintDec 3rd, 2017

Gizmo Geek: Extravagant Gadgets

Gizmo Geek: Extravagant Gadgets.....»»

Category: topSource: mydigitalfcNov 17th, 2017

Zydus Cadila, Intas under scanner for launching hypertension drug without permit

Zydus Cadila, Intas under scanner for launching hypertension drug without permit.....»»

Category: featuresSource: livemintNov 9th, 2017

Teva in talks to set up joint venture with China’s Guangzhou Pharma

Teva in talks to set up joint venture with China’s Guangzhou Pharma.....»»

Category: featuresSource: livemintNov 2nd, 2017

US generic drug price-fixing conspiracy jolts Indian pharma companies

US generic drug price-fixing conspiracy jolts Indian pharma companies.....»»

Category: topSource: livemintNov 1st, 2017

Indian generic drug makers jolted by US price-fixing conspiracy

Indian generic drug makers jolted by US price-fixing conspiracy.....»»

Category: topSource: livemintNov 1st, 2017

Torrent Pharma in advanced talks to buy Unichem’s India business for Rs3,200-3,300 crore

Torrent Pharma in advanced talks to buy Unichem’s India business for Rs3,200-3,300 crore.....»»

Category: featuresSource: livemintOct 30th, 2017

Artificial intelligence, safety, and end-of-life care

Artificial intelligence, safety, and end-of-life care.....»»

Category: opinionSource: livemintOct 23rd, 2017